Author:
Bloom Allyson K,Ryan Edward T
Reference5 articles.
1. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in Human Immunodeficiency Virus-infected patients with allergy to trimethoprim/sulfamethoxazole;Beumont;Am J Med,1996
2. Dapsone: Modes of action, toxicity, and possible strategies for increasing patient tolerance;Coleman;Br J Derm,1993
3. Dapsone Treatment of Pneumocystis carinii pneumonia in the Acquired Immunodeficiency Syndrome;Mills;Antimicrob Agents and Chemo,1988
4. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia;Mohle-Boetani;West J Med,1992
5. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS: A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine;Safrin;Ann Intern Med,1996